关注
Matthew D Galbraith
Matthew D Galbraith
Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus
在 cuanschutz.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transcriptional regulation by hypoxia inducible factors
VL Dengler, MD Galbraith, JM Espinosa
Critical reviews in biochemistry and molecular biology 49 (1), 1-15, 2014
8562014
Mechanisms of transcriptional regulation by p53
KD Sullivan, MD Galbraith, Z Andrysik, JM Espinosa
Cell Death & Differentiation 25 (1), 133-143, 2018
4432018
HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia
MD Galbraith, MA Allen, CL Bensard, X Wang, MK Schwinn, B Qin, ...
Cell 153 (6), 1327-1339, 2013
3712013
Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
MA Allen, Z Andrysik, VL Dengler, HS Mellert, A Guarnieri, JA Freeman, ...
Elife 3, e02200, 2014
2662014
Trisomy 21 consistently activates the interferon response
KD Sullivan, HC Lewis, AA Hill, A Pandey, LP Jackson, JM Cabral, ...
eLife 5, e16220, 2016
2622016
CDK8: a positive regulator of transcription
MD Galbraith, AJ Donner, JM Espinosa
Transcription 1 (1), 4-12, 2010
2602010
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity
Z Andrysik, MD Galbraith, AL Guarnieri, S Zaccara, KD Sullivan, A Pandey, ...
Genome research 27 (10), 1645-1657, 2017
1422017
Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1
HM Zhang, L Li, N Papadopoulou, G Hodgson, E Evans, M Galbraith, ...
Nucleic acids research 36 (8), 2594-2607, 2008
1052008
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome
KA Waugh, P Araya, A Pandey, KR Jordan, KP Smith, RE Granrath, ...
Cell reports 29 (7), 1893-1908. e4, 2019
952019
The TIP60 Complex Is a Conserved Coactivator of HIF1A
JI Perez-Perri, VL Dengler, KA Audetat, A Pandey, EA Bonner, M Urh, ...
Cell Reports 16 (1), 37-47, 2016
912016
Therapeutic targeting of transcriptional cyclin-dependent kinases
MD Galbraith, H Bender, JM Espinosa
Transcription 10 (2), 118-136, 2019
872019
CDK8 Kinase Activity Promotes Glycolysis
MD Galbraith, Z Andrysik, A Pandey, M Hoh, EA Bonner, AA Hill, ...
Cell Reports 21 (6), 1495-1506, 2017
852017
Biochemical and genetic diversity of pectolytic enterobacteria causing soft rot disease of potatoes in New Zealand
AR Pitman, PJ Wright, MD Galbraith, SA Harrow
Australasian Plant Pathology 37, 559-568, 2008
822008
A kinase-independent role for cyclin-dependent kinase 19 in p53 response
KA Audetat, MD Galbraith, AT Odell, T Lee, A Pandey, JM Espinosa, ...
Molecular and cellular biology, 2017
782017
Specialized interferon action in COVID-19
MD Galbraith, KT Kinning, KD Sullivan, P Araya, KP Smith, RE Granrath, ...
Proceedings of the National Academy of Sciences 119 (11), e2116730119, 2022
772022
Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions
I Steinparzer, V Sedlyarov, JD Rubin, K Eislmayr, MD Galbraith, ...
Molecular cell 76 (3), 485-499. e8, 2019
672019
Mutual exclusivity of MED12/MED12L, MED13/13L, and CDK8/19 paralogs revealed within the CDK-Mediator kinase module
DL Daniels, M Ford, MK Schwinn, H Benink, MD Galbraith, ...
J Proteomics Bioinform S 2 (2), 2013
662013
Seroconversion stages COVID19 into distinct pathophysiological states
MD Galbraith, KT Kinning, KD Sullivan, R Baxter, P Araya, KR Jordan, ...
Elife 10, e65508, 2021
502021
Multi-omics analysis reveals contextual tumor suppressive and oncogenic gene modules within the acute hypoxic response
Z Andrysik, H Bender, MD Galbraith, JM Espinosa
Nature Communications 12 (1), 1375, 2021
422021
ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas
CG Abraham, MP Ludwig, Z Andrysik, A Pandey, M Joshi, MD Galbraith, ...
Cell reports 24 (12), 3224-3236, 2018
422018
系统目前无法执行此操作,请稍后再试。
文章 1–20